Virtue Capital Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
Virtue Capital Management's IHE Position: Q3 2026 in Review
Virtue Capital Management opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q3 2026: 62,063 shares worth $6.24M. The stake represents 0.81% of the portfolio and ranks #27 among its holdings. This is a return to the name: Virtue Capital Management previously reported a position in IHE as recently as Q1 2026.
Virtue Capital Management first reported a position in IHE in Q1 2024 and has held it in 3 quarters since. The position peaked at $6.43M in Q1 2026. 249 funds tracked by Wall St. Rank hold IHE as of Q3 2026.
- Virtue Capital Management held 62,063 shares of iShares US Pharmaceuticals ETF worth $6.24M as of Q3 2026.
- iShares US Pharmaceuticals ETF was a new Virtue Capital Management position in Q3 2026.
- iShares US Pharmaceuticals ETF made up 0.81% of Virtue Capital Management's portfolio in Q3 2026, its #27 holding.
- Virtue Capital Management first reported a position in iShares US Pharmaceuticals ETF in Q1 2024 and has held it in 3 quarters since.
- Virtue Capital Management's iShares US Pharmaceuticals ETF position peaked at $6.43M in Q1 2026.
- 249 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.
Based on Virtue Capital Management's 13F filing for Q3 2026, filed 29 Oct 2026.